InsidersTradesSigma
Track the Pharmanutra PR - First Sales on the US Market share price and the full insider trade history of the company, a listed equity based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra PR - First Sales on the US Market has published 1 public disclosures. Market capitalisation: €804.3m. The latest transaction was reported on 3 October 2023 (Other). Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Pharmanutra PR 已在美国市场实现首次销售，标志着其国际扩张的重要里程碑。该公司专注于创新医药产品的开发。